The Tesla Shock Nobody Sees Coming

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Here's How Much $1000 Invested In Union Pacific 20 Years Ago Would Be Worth Today

Union Pacific (NYSE: UNP) has outperformed the market over the past 20 years by 4.88% on an annualized basis producing an average annual return of 13.7%. Currently, Union Pacific has a market capitalization of $138.27 billion.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

Jerome Powell and Economists Agree: Gen Z Faces a Hiring Crisis And That's Not About AI

In 2025, the rising unemployment rate among Americans under 25, specifically recent graduates, has become a significant economic concern.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chro

Power, politics and performance: Russia's revamped Intervision song contest names a winner

When Vietnamese singer Duc Phuc held aloft the crystal cup trophy in Moscow’s Live Arena on Saturday night, he became the inaugural winner of — a Russian answer to Eurovision that some say is as much about politics and power as it is about performance.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

FedEx Bets On Cost Cuts To Boost Margins, Says Analyst

FDX shares surge on strong quarterly performance, exceeding revenue and profit expectations. Bank of America raises price forecast to $244.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

MediaTek Adopts Taiwan Semiconductor 2nm Breakthrough For Flagship Chip

MediaTek partners with TSMC to develop a flagship SoC using the new 2nm process, a major leap for both companies.

Gold Success Absent From Fund Allocation, Survey Shows

Gold is soaring to its second-best year in half a century, up over 43% as investors hedge against inflation and geopolitical risks.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Qatar denounces Israel before major summit on Israel's attack in Doha targeting Hamas leaders

DUBAI, United Arab Emirates (AP) — Qatar's prime minister denounced Israel on Sunday as foreign ministers from Arab and Muslim nations met to discuss a possible unified targeting the leadership of the militant group Hamas.

US sanctions Iranian financiers, others over $100M in cryptocurrency transfers from Iran oil sales

WASHINGTON (AP) — A pair of Iranian financiers and more than a dozen people and firms across Hong Kong and the United Arab Emirates were sanctioned Tuesday for allegedly coordinating $100 million worth of cryptocurrency transfers from the sale of Iranian oil for the benefit of Iran's government and military.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion

Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.

US To Impose $100,000 Annual Fee On H-1B Visas As Analysts Warn Trump Risks 'Taxing Away' America's Innovation Edge

The Trump administration's plan to impose a $100,000 annual fee on H-1B visas could reshape tech hiring, strain talent pipelines from India and China, and risk driving innovation overseas, analysts warn.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

XPeng Joins Forces With Magna To Build EVs In Austria

XPeng and Magna partner to assemble EVs in Europe, making XPeng first Chinese carmaker to localize production on the continent. Q3 2025 start.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

Will electric tractors gain traction? At a pilot event for farmers, researchers see possibilities

EAST LANSING, Mich. (AP) — In the soft dirt of an indoor horseback riding ring last month, a group of farmers got ready to test drive a new piece of equipment: an electric tractor.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Tesla, Delta Air, Teck Resources And A Financial Stock On CNBC's 'Final Trades'

Joshua Brown, CEO of Ritholtz Wealth Management, is bullish on Rocket Companies (RKT) as it has officially broken out. Delta Air Lines (DAL), Teck Resources (TECK) and Tesla (TSLA) also discussed on CNBC's Halftime Report.

Hong Kong leader unveils plans to boost economy and nurture emerging industries beyond finance

HONG KONG (AP) — Hong Kong's leader announced plans Wednesday to speed up development of an economic powerhouse near its border with mainland China and nurture industries ranging from artificial intelligence to higher education as the city seeks new economic growth engines to maintain its international competitiveness.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Canada's Carney heads to Mexico to discuss trade before a review of their US trade deal

TORONTO (AP) — Canadian Prime Minister Mark Carney heads to Mexico on Thursday in an effort to diversify trade as America’s neighbors brace for a review of the free trade deal with United States.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Utah Governor After Kirk Killing: 'Social Media Is A Cancer On Our Society Right Now'

Utah Gov. Spencer Cox urged unity after Charlie Kirk's killing, warning that "social media is a cancer on our society right now."

Trump Says 'There'll Be Others' After Comey Indictment, Slams 'Corrupt Radical Left Democrats'

On Friday, President Donald Trump stated that he anticipates more individuals will be charged, following the Justice Department’s indictment of former FBI Director James Comey the day before.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service